missing translation for 'onlineSavingsMsg'
Learn More
Learn More
SARS-CoV-2 Spike RBD Antibody, R&D Systems™
Mouse Monoclonal Antibody
Brand: R&D Systems MAB105807-SP
This item is not returnable.
View return policy
Description
Spike RBD Monoclonal specifically detects Spike RBD in SARS-CoV-2 samples. It is validated for ELISA, Blockade of Receptor-ligand Interaction.
Specifications
SARS-CoV-2 Spike RBD | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 µm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS. | |
2019-nCoV Peplomer protein, 2019-nCoV S Protein, 2019-nCoV Spike, COVID-19 Spike, E2, Human coronavirus spike glycoprotein, Peplomer protein, S glycoprotein, S protein, SARS-CoV-2, SARS-COV-2 E2, SARS-COV-2 Peplomer protein, SARS-COV-2 S protein, SARS-COV-2 Spike glycoprotein, SARSCOV2 Spike protein, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein, Spike, Spike glycoprotein, Spike S1, Spike S1 RBD, surface glycoprotein | |
Spodoptera frugiperda, Sf 21 (baculovirus)-derived SARS-CoV-2 Spike S1 Subunit, Val16-Pro681, Accession # YP_009724390.1 | |
25 μg | |
Primary | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. | |
IgG2a |
ELISA, Blocking Assay | |
1035740 | |
ELISA, Blockade of Receptor-ligand Interaction 50 ug/mL | |
YP_009724390.1 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
43740568 | |
SARS-CoV-2 | |
Purified |
Product Suggestions
Customers who viewed this item also viewed.
Viewing 1-4 of
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
SARS-CoV-2 Spike RBD Antibody, R&D Systems™ > 25 μg; Unconjugated
Spot an opportunity for improvement?Share a Content Correction